NO20021607D0 - Kationiske DOSPER-virosomer - Google Patents

Kationiske DOSPER-virosomer

Info

Publication number
NO20021607D0
NO20021607D0 NO20021607A NO20021607A NO20021607D0 NO 20021607 D0 NO20021607 D0 NO 20021607D0 NO 20021607 A NO20021607 A NO 20021607A NO 20021607 A NO20021607 A NO 20021607A NO 20021607 D0 NO20021607 D0 NO 20021607D0
Authority
NO
Norway
Prior art keywords
cationic
virosomes
lipids
virosome
relates
Prior art date
Application number
NO20021607A
Other languages
English (en)
Other versions
NO20021607L (no
Inventor
Ernst Rudolf Waelti
Reinhard Glueck
Peter Klein
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/414,872 external-priority patent/US6210708B1/en
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of NO20021607D0 publication Critical patent/NO20021607D0/no
Publication of NO20021607L publication Critical patent/NO20021607L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20021607A 1999-10-08 2002-04-05 Kationiske DOSPER-virosomer NO20021607L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/414,872 US6210708B1 (en) 1996-05-08 1999-10-08 Cationic virosomes as transfer system for genetic material
PCT/EP2000/009540 WO2001026628A1 (en) 1999-10-08 2000-09-29 Cationic dosper virosomes

Publications (2)

Publication Number Publication Date
NO20021607D0 true NO20021607D0 (no) 2002-04-05
NO20021607L NO20021607L (no) 2002-06-07

Family

ID=23643351

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021607A NO20021607L (no) 1999-10-08 2002-04-05 Kationiske DOSPER-virosomer

Country Status (19)

Country Link
EP (1) EP1217990B1 (no)
JP (1) JP2003512306A (no)
KR (1) KR100869195B1 (no)
AT (1) ATE258428T1 (no)
AU (1) AU778399B2 (no)
CA (1) CA2388053A1 (no)
CO (1) CO5280052A1 (no)
CZ (1) CZ20021216A3 (no)
DE (1) DE60008006T2 (no)
DK (1) DK1217990T3 (no)
ES (1) ES2215073T3 (no)
HU (1) HUP0202809A2 (no)
NO (1) NO20021607L (no)
PE (1) PE20010703A1 (no)
PL (1) PL355231A1 (no)
RU (1) RU2002112224A (no)
SK (1) SK4782002A3 (no)
TR (1) TR200200930T2 (no)
WO (1) WO2001026628A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100488491C (zh) * 2002-11-21 2009-05-20 派维翁生物技术有限公司 高效融合小泡,其制备方法和含有该小泡的药物组合物
JP4497894B2 (ja) * 2003-11-07 2010-07-07 明彦 河合 物質導入剤およびその製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL296382A1 (en) * 1991-02-02 1993-11-02 Nika Health Products Ltd Li Li Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system
DE19521412A1 (de) * 1995-06-14 1996-12-19 Boehringer Mannheim Gmbh Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung
NZ332666A (en) * 1996-05-08 2000-05-26 Nika Health Products Ltd Cationic virosomes having a positively charged lipid bilayer membrane with an integrated viral fusogenic peptide as genetic transfer systems for use in gene therapy
ATE340259T1 (de) * 1996-07-16 2006-10-15 Archibald James Mixson Kationisches vehikel: dns komplexe und ihre verwendung in gentherapie

Also Published As

Publication number Publication date
PL355231A1 (en) 2004-04-05
EP1217990B1 (en) 2004-01-28
PE20010703A1 (es) 2001-07-11
DE60008006T2 (de) 2004-09-09
CZ20021216A3 (cs) 2002-10-16
WO2001026628A1 (en) 2001-04-19
AU778399B2 (en) 2004-12-02
CA2388053A1 (en) 2001-04-19
CO5280052A1 (es) 2003-05-30
DK1217990T3 (da) 2004-05-24
JP2003512306A (ja) 2003-04-02
KR20020063872A (ko) 2002-08-05
TR200200930T2 (tr) 2002-08-21
EP1217990A1 (en) 2002-07-03
NO20021607L (no) 2002-06-07
RU2002112224A (ru) 2004-01-10
SK4782002A3 (en) 2002-09-10
AU7785000A (en) 2001-04-23
ES2215073T3 (es) 2004-10-01
HUP0202809A2 (hu) 2002-12-28
ATE258428T1 (de) 2004-02-15
KR100869195B1 (ko) 2008-11-18
DE60008006D1 (de) 2004-03-04

Similar Documents

Publication Publication Date Title
Ruponen et al. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies
Cortesi et al. Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA
KR101168440B1 (ko) 지질 캡슐화된 간섭 ｒｎａ
US20230212578A1 (en) Compositions and methods for treating hypertriglyceridemia
CN101346393B (zh) 修饰的siRNA分子及其应用
Pupo et al. Preparation of plasmid DNA-containing liposomes using a high-pressure homogenization–extrusion technique
CA2506593A1 (en) High-efficiency fusogenic vesicles, methods of producing them, and pharmaceutical compositions containing them
WO2007031333A3 (en) Improvements in or relating to amphoteric liposomes
EP2335687B1 (en) Use of monoolein as a new auxiliary lipid in lipofection
AU5161800A (en) Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
Sen et al. Design, syntheses, and transfection biology of novel non-cholesterol-based guanidinylated cationic lipids
NZ332666A (en) Cationic virosomes having a positively charged lipid bilayer membrane with an integrated viral fusogenic peptide as genetic transfer systems for use in gene therapy
EP1764089A1 (en) Serum stable liposomes comprising amphoter II lipid mixtures
CN102481256A (zh) 包含亚氨基脂质的两性脂质体
Karmali et al. In vitro gene transfer efficacies and serum compatibility profiles of novel mono-, di-, and tri-histidinylated cationic transfection lipids: a structure− activity investigation
WO2003057164A3 (en) Compounds for delivering substances into cells
CN1915968A (zh) 用于核酸及药物传递的中性－阳离子类脂
WO2003102150A3 (en) Multi-functional polyamines for delivery of biologically-active polynucleotides
Pierrat et al. Characterization of titratable amphiphiles in lipid membranes by fluorescence spectroscopy
ATE258428T1 (de) Kationische dosper virosomen
DK2140870T3 (en) The carrier composition for immediate nukleinsyrefremføring
Sen et al. Gene transfer efficacies of novel cationic amphiphiles with alanine, β-alanine, and serine headgroups: a structure− activity investigation
Majeti et al. In vitro gene transfer efficacies of N, N-dialkylpyrrolidinium chlorides: a structure− activity investigation
WO2001042424A3 (en) Sphingolipid-containing cationic liposomes for topical delivery of bioactive material
Sheikh et al. In vitro lipofection with novel series of symmetric 1, 3-dialkoylamidopropane-based cationic surfactants containing single primary and tertiary amine polar head groups

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application